Feasibility Study for Improving the Relevance of Diagnostic Proposals for an Artificial Intelligence Software in the Elderly Population.
Trial ID: NCT04242043
Status: COMPLETED
Study type: OBSERVATIONAL
Start date: 2019-12-21
Completion date: 2020-09-22
Sponsor: University Hospital, Limoges
Conditions: Artificial Intelligence; Geriatrics; Diagnostic Proposals Elderly
Interventions: intel@med-feasibility
Locations: Ehpad Des Bayles; Ehpad Le Roussillon
Countries: France; France
Enrollment: 18
Age range: 65 Years - None
Sex: ALL

Summary:
The ageing of the population is accompanied by the problem of chronic pathologies and sometimes heavy dependence, requiring admission to Nursing Homes (NHs). Approximately 660,000 people currently live in NHs in France. One out of 3 NHs does not have a coordinating doctor, even though the law requires it, and access to care in these NHs is very unequal nationally and especially in the Limousin and Dordogne regions. Some Hospices may find themselves in a situation where there is no coordinating doctor and difficult access to General Practitioners (GPs) visiting a large area.

This inequality of access to care results in a difference in care that can go as far as a loss of opportunity for residents who are immediately transferred to the emergency department (ED) with a risk of iatrogeny or delirium once in the ED or a risk of inappropriate hospitalization.

Residents are hospitalized:

* when the latter could have been avoided because the health care team, not knowing what attitude to adopt, prioritized hospitalization
* Late because the resident waited for the attending physician to come, which resulted in a worsening of symptoms.

The arrival of Artificial Intelligence (AI) is an opportunity to find new models of care organization that can mitigate medical desertification but also develop advanced practices in gerontology. For example, nurses will be able to intervene at a first level for early detection, better triage and early management of certain pathologies.

The "MEDVIR society" AI, developed by a French company, is a medical decision support system with Artificial Intelligence and offers pre-diagnosis based on the information collected (medical and surgical history, concomitant treatments and symptoms). MEDVIR is a diagnostic aid tool and does not replace the doctor who remains at the end of the chain, the final decision-maker.

Before research is conducted to integrate this technology into routine care, it is important to validate the diagnostic relevance of AI in the elderly, as it has been validated in the general population.

This pilot feasibility study will then enable us to methodologically dimension a future project to evaluate the efficiency of this new care system in the management of elderly patients in medical deserts in France.

Eligibility criteria:
Inclusion Criteria:

* Patient aged 65 or over
* Patient living in one of the two NHs tests
* Patient with a functional complaint or abnormal symptoms involving the call of a physician
* Patient or his legal representative who has not expressed his opposition to the collection of his medical and personal data
* Patient affiliated to social security

Exclusion Criteria:

* End-of-life patient
* Patient with a clear vital emergency according to the physician
* Chronic aphasic patient

Outcomes:
AI diagnostic proposals